EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Challenges and solutions for upstream processing of complex biologics

Shuya Xu, Yunlong Wang, Yawen Yu, Felix Zhu, Ying Li iD

Antibody Therapeutics · 01.04.2026 · 9 (2) · 139-149

DOI: 10.1093/abt/tbag008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibody Therapeutics, online erschienen am 09.03.2026. Verfasst von Shuya Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Process Development, GenScript ProBio Biotechnology Co., Ltd, Nanjing 21100, China. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GenScript ProBio Biotechnology Co., LTD..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unlike conventional monoclonal antibodies, complex biologics—such as bispecific antibodies and fusion proteins—often face challenges including lower expression levels, higher mispairing rates, and greater sensitivity to culture conditions, which can collectively limit both titer and product quality. Leveraging process development case studies, this review systematically explores upstream bioprocessing strategies aimed at mitigating these challenges, with a focus on titer enhancement, lactate metabolism regulation, acidic charge variants control, reduction of aggregates and fragments, and glycosylation optimization. Finally, a perspective toward future upstream development strategies is discussed.

Schlagwörter

Stichwörter der Autor:innen

cell culturebispecific antibodyfusion proteinquality improvementtiter enhancementupstream processing

Autor:innen und Institutionen

  • Department of Antibody Process Development, GenScript ProBio Biotechnology Co., Ltd, Nanjing 21100, China.

ORCID-Profile: Ying Li

Förderung

  • GenScript ProBio Biotechnology Co., LTD.

Zitieren

APA

Xu, S., Wang, Y., Yu, Y., Zhu, F., & Li, Y. (2026). Challenges and solutions for upstream processing of complex biologics. Antibody Therapeutics, 9(2), 139-149. https://doi.org/10.1093/abt/tbag008

Vancouver

Xu S, Wang Y, Yu Y, Zhu F, Li Y. Challenges and solutions for upstream processing of complex biologics. Antibody Therapeutics. 2026;9(2):139-149. doi:10.1093/abt/tbag008

BibTeX
@article{Xu2026,
  author = {Xu, Shuya and Wang, Yunlong and Yu, Yawen and Zhu, Felix and Li, Ying},
  title = {Challenges and solutions for upstream processing of complex biologics},
  journal = {Antibody Therapeutics},
  year = {2026},
  volume = {9},
  number = {2},
  pages = {139--149},
  doi = {10.1093/abt/tbag008}
}
Kostenlos starten →